Earnings Call · Q2 FY2023·2023-08-09

Q2 23EPS +91.04%·Rev n/aQ1 23EPS +100.00%*·Rev n/aQ4 22EPS +13.43%·Rev n/aQ3 22EPS +16.36%·Rev n/a⚠ consensus missing

ANI PHARMACEUTICALS INC ANIP

Judy DiClemente — Investor Relations

Nikhil Lalwani — President and Chief Executive Officer

Stephen Carey — Chief Financial Officer

+9.2%1d on move date+9.9% vs SPY3d+12.0%5d+10.7%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ANIP calls or request research access.

More ANIP calls Browse calls Request research access